Korean J Med > Volume 78(4); 2010 > Article
The Korean Journal of Medicine 2010;78(4):503-506.
A case of thyrotoxicosis after sunitinib treatment
Ho Young Lee, Mi Kyung Kim, Nam Keong Kim, Hye Soon Kim, Seong-Yeol Ryu, Ki Young Kwon, Keun Gyu Park
Sunitinib 치료 이후 발생한 갑상선중독증 1예
이호영, 김미경, 김남경, 김혜순, 류성열, 권기영, 박근규
Abstract
Sunitinib is a tyrosine-kinase inhibitor used to treat metastatic renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumors. Hypothyroidism is a common side effect of sunitinib therapy. Nevertheless, overt thyrotoxicosis induced by destructive thyroiditis after sunitinib treatment is very rare. Here, we report a patient with overt thyrotoxicosis related to sunitinib therapy.
Key Words: Sunitinib; Thyrotoxicosis


TOOLS
METRICS Graph View
  • 1,320 View
  • 6 Download

Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791    Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr                

Copyright © 2024 by The Korean Association of Internal Medicine.

Developed in M2PI

Close layer
prev next